KR102824686B1 - 면역원성 작용제로서 스트렙토코쿠스 우베리스 추출물 - Google Patents

면역원성 작용제로서 스트렙토코쿠스 우베리스 추출물 Download PDF

Info

Publication number
KR102824686B1
KR102824686B1 KR1020187021575A KR20187021575A KR102824686B1 KR 102824686 B1 KR102824686 B1 KR 102824686B1 KR 1020187021575 A KR1020187021575 A KR 1020187021575A KR 20187021575 A KR20187021575 A KR 20187021575A KR 102824686 B1 KR102824686 B1 KR 102824686B1
Authority
KR
South Korea
Prior art keywords
mastitis
uberis
vaccine
biofilm
immunogenic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020187021575A
Other languages
English (en)
Korean (ko)
Other versions
KR20180108619A (ko
Inventor
힘베르트 로사 마리아 코야도
이 아마르고스 안토니 프레나페타
Original Assignee
히프라 사이언티픽, 에스.엘.유
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 히프라 사이언티픽, 에스.엘.유 filed Critical 히프라 사이언티픽, 에스.엘.유
Publication of KR20180108619A publication Critical patent/KR20180108619A/ko
Application granted granted Critical
Publication of KR102824686B1 publication Critical patent/KR102824686B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1020187021575A 2016-02-15 2017-02-14 면역원성 작용제로서 스트렙토코쿠스 우베리스 추출물 Active KR102824686B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16382060.8 2016-02-15
EP16382060 2016-02-15
PCT/EP2017/053306 WO2017140683A2 (en) 2016-02-15 2017-02-14 Streptococcus uberis extract as an immunogenic agent

Publications (2)

Publication Number Publication Date
KR20180108619A KR20180108619A (ko) 2018-10-04
KR102824686B1 true KR102824686B1 (ko) 2025-06-25

Family

ID=55646514

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020187021575A Active KR102824686B1 (ko) 2016-02-15 2017-02-14 면역원성 작용제로서 스트렙토코쿠스 우베리스 추출물

Country Status (11)

Country Link
US (1) US10946085B2 (enExample)
EP (1) EP3417049B1 (enExample)
JP (1) JP6839199B2 (enExample)
KR (1) KR102824686B1 (enExample)
AU (1) AU2017220528A1 (enExample)
CA (1) CA3012419A1 (enExample)
ES (1) ES2960326T3 (enExample)
MX (1) MX387200B (enExample)
PL (1) PL3417049T3 (enExample)
WO (1) WO2017140683A2 (enExample)
ZA (1) ZA201805039B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022352157A1 (en) 2021-09-21 2024-05-02 National Agriculture And Food Research Organization Vaccine including nonencapsulated strain as antigen
EP4570265A1 (en) 2023-12-15 2025-06-18 Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. Vaccine for use in preventing inflammatory conditions in cows

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60243024A (ja) * 1983-12-29 1985-12-03 Kitasato Inst:The ストレプトコツカス・サンギス感染症予防用ワクチン，診断用抗原および抗体
CA2059693C (en) * 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
CA2222701C (en) 1995-06-08 2012-02-07 University Of Saskatchewan Camp factor of streptococcus uberis
DK1332155T3 (da) 2000-06-12 2007-02-26 Univ Saskatchewan Vaccination af malkekvæg med GapC protein mod streptokokinfektion
US20070231335A1 (en) * 2005-07-20 2007-10-04 Bruce Beutler Compositions and methods for treating Gram positive bacterial infection in a mammalian subject
US8273361B2 (en) 2006-09-26 2012-09-25 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
US20110028407A1 (en) * 2007-02-09 2011-02-03 Jutila Mark A Enhancement of innate resistance to infection
GB0818231D0 (en) 2008-10-06 2008-11-12 Univ Nottingham Composition
EP3461496B1 (en) * 2009-06-22 2023-08-23 Wyeth LLC Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
WO2012116447A1 (en) 2011-03-03 2012-09-07 The Governors Of The University Of Alberta Use of bacterial endotoxins and lipoteichoic acids to improve postpartal health and productivity of dairy cows and their newborns
MX2013013182A (es) 2011-05-12 2013-12-09 Intervet Int Bv Tratamiento de la mastitis.
BR112013032675A2 (pt) * 2011-06-19 2017-08-08 Vaxine Pty Ltd composição adjuvante de vacina compreendendo partículas de inulina
WO2015042423A2 (en) 2013-09-19 2015-03-26 Zoetis Llc Vaccine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Vet Immunol Immunopathol. 2014 Jul 15,160(1-2):51-60.*
Veterinary Research. 2016, 47, Article number: 13.*

Also Published As

Publication number Publication date
EP3417049A2 (en) 2018-12-26
PL3417049T3 (pl) 2024-02-19
CA3012419A1 (en) 2017-08-24
WO2017140683A2 (en) 2017-08-24
ZA201805039B (en) 2020-05-27
JP6839199B2 (ja) 2021-03-03
ES2960326T3 (es) 2024-03-04
MX387200B (es) 2025-03-18
US20190038736A1 (en) 2019-02-07
MX2018009048A (es) 2019-03-28
KR20180108619A (ko) 2018-10-04
JP2019504623A (ja) 2019-02-21
AU2017220528A1 (en) 2018-08-09
EP3417049B1 (en) 2023-08-16
BR112018015255A2 (pt) 2018-12-18
WO2017140683A3 (en) 2017-10-12
US10946085B2 (en) 2021-03-16

Similar Documents

Publication Publication Date Title
Nordhaug et al. A field trial with an experimental vaccine against Staphylococcus aureus mastitis in cattle. 1. Clinical parameters
US10434168B2 (en) Attenuated bovine coronavirus and related vaccines
EP2480240B1 (en) Modified gram-negative bacteria for use as vaccines
JP2023503057A (ja) ヘモフィルス・パラスイスに対する新規ワクチン
JP2002519388A (ja) ヘモフィルス・パラスイスのワクチン及び診断薬
JP2023503058A (ja) ヘモフィルス・パラスイスに対する新規ワクチン
KR102824686B1 (ko) 면역원성 작용제로서 스트렙토코쿠스 우베리스 추출물
KR20200076551A (ko) 마이코플라즈마 폐렴 및 흉막폐렴 예방용 백신 조성물
WO1993010815A1 (en) Non-capsulated mutants of bacteria useful as vaccines
WO2006106424A2 (en) Formulations and process for production of bordetella bronchiseptica p68 antigen and vaccines
US12383610B2 (en) Vaccine for protection against Streptococcus suis serotype 9, sequence type 16
BR112018015255B1 (pt) Processo para a preparação de um agente imunogênico, vacina, kit de vacinação e uso de um biofilme tratado termicamente com calor
US20090269826A1 (en) Vaccine against streptococcus agalactiae infection using native or recombinant s. agalactiae glyceraldheyde-3-phosphate dehydrogenase (gapdh) as a target antigen
KR100258772B1 (ko) 돼지의 흉막폐염 백신 조성물
RU2833948C1 (ru) Новая вакцина против heamophilus parasuis
RU2822516C1 (ru) Новая вакцина против haemophilus parasuis
Kenny et al. The enhancement of bovine mammary gland immunity through vaccination
US20240335520A1 (en) A vaccine for protection against streptococcus suis of various serotypes
Hajizadeh et al. Bactericidal Activity of Serum by Brucella Abortus RB51 Outer Membrane Protein’s Combined by Brucella Abortus S99 Lipopolysaccharide Induction
US20080226661A1 (en) Phage Screening Assay

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20180726

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20220211

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20241120

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20250321

PG1601 Publication of registration